Corvex CFO granted 523,211 restricted shares

Corvex, Inc. reported that CFO Christopher Moreland received an equity grant of 523,211 shares of Common Stock on July 1, 2026.

Rhea-AI Filing Summary

Corvex, Inc. reported that CFO Christopher Moreland received an equity grant of 523,211 shares of Common Stock on July 1, 2026. The Form 4 classifies this as a grant or award acquisition at a stated price of $0.00 per share, reflecting compensation rather than a market purchase.

According to the footnote, these shares are time-based restricted stock units that vest in four equal annual installments from the grant date. After this award, Moreland directly holds 523,211 shares, and the filing shows no open-market buys or sells and no remaining derivative positions.

Insider Trade Summary

Grant/Award: 523,211 shares

Grant/Award 1 txn

Insider Moreland Christopher

Role CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	523,211	$0.00	$0.00

Holdings After Transaction: Common Stock — 523,211 shares (Direct)

Footnotes (1)

1. F1. Represents time-based restricted stock units that vest in four equal annual installments from the grant date.

Key Figures

Shares granted: 523,211 shares Grant price per share: $0.00 per share Shares owned after grant: 523,211 shares +2 more

5 metrics

Shares granted 523,211 shares Time-based restricted stock units granted on July 1, 2026

Grant price per share $0.00 per share Stated transaction price for RSU grant

Shares owned after grant 523,211 shares Total direct holdings following the reported transaction

Vesting schedule Four equal annual installments Time-based RSUs vesting from the grant date

Transaction type Grant, award, or other acquisition Form 4 code A, non-derivative Common Stock

Key Terms

time-based restricted stock units, Form 4, grant, award, or other acquisition, non-derivative

4 terms

time-based restricted stock units financial

"Represents time-based restricted stock units that vest in four equal annual installments"

Time-based restricted stock units are a form of employee compensation where individuals are granted company shares that are earned over a set period, often as a reward for staying with the company. These shares typically become fully owned and transferable only after passing specific time milestones, encouraging long-term commitment. For investors, they highlight a company's focus on employee retention and can influence future stock supply and company stability.

Form 4 regulatory

"The Form 4 classifies this as a grant or award acquisition"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

non-derivative financial

"transaction_type": "non-derivative""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Corvex (MOVE) CFO Christopher Moreland report in this Form 4?

CFO Christopher Moreland reported receiving an equity grant of 523,211 shares of Corvex Common Stock. The grant is recorded at $0.00 per share, indicating a compensation award rather than an open-market purchase, and increases his directly held shares to the same amount.

Is the Corvex (MOVE) CFO Form 4 transaction a buy or a grant?

The Form 4 shows a grant or award acquisition, not an open-market buy. Code "A" and the description "grant, award, or other acquisition" indicate compensation-related restricted stock units rather than a discretionary stock purchase by the CFO in the market.

How many Corvex (MOVE) shares were granted to the CFO in this filing?

The filing reports a grant of 523,211 shares of Common Stock to CFO Christopher Moreland. After this award, his total direct ownership is also 523,211 shares, with no additional derivative holdings shown in the accompanying transaction and derivative summaries.

How do the Corvex (MOVE) CFO’s restricted stock units vest?

The footnote explains these are time-based restricted stock units that vest in four equal annual installments starting from the grant date. This structure ties full ownership to continued service over several years, a common form of long-term executive compensation.

Did the Corvex (MOVE) Form 4 show any stock sales by the CFO?

No stock sales were reported for the CFO in this Form 4. The transaction summary shows one acquisition via grant, with no buy or sell transactions, no gifts, and no tax-withholding dispositions, indicating a purely compensation-related award in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 09:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moreland Christopher

(Last) (First) (Middle)

C/O CORVEX, INC.

3401 NORTH FAIRFAX DRIVE, SUITE 3230

(Street)

ARLINGTON VIRGINIA 22226

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Corvex, Inc. [ MOVE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		523,211(1)	A	$0	523,211	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents time-based restricted stock units that vest in four equal annual installments from the grant date.

	/s/ Chance Moreland by Mark R. Busch, attorney-in-fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)